The Orthopedic Future: Collaboration Across Care Teams The rise of GLP-1 medications has opened a new chapter in multidisciplinary care
In the STEP 4 trial, participants who stopped semaglutide regained about two-thirds of the weight they had lost within one year (STEP 4 withdrawal study)
Recent clinical data show semaglutide 2.4 mg achieved 14.9% mean weight loss at 68 weeks in STEP 1, while tirzepatidewhich targets dual GLP-1 and GIP receptorsproduces 2027% weight loss in comparable trials, yet individual outcomes vary significantly based on genetic predispositions in appetite and energy metabolism pathways
After the shot, press gently on the site with a clean cotton ball instead of rubbing the skin
Pair each fiber increase with extra fluid so stool does not become bulkier but still dry
Before beginning Ozempic treatment at Vive Ageless Weight Loss Center, its essential to take preparatory steps to ensure the medication aligns with your weight loss and health goals